Enfermedad de las arterias coronarias.

Por el personal de Mayo Clinic
15 de septiembre de 2026

Investigación

Los investigadores de Mayo Clinic desarrollan e investigan potenciales métodos de diagnóstico y tratamientos para las personas con enfermedad de las arterias coronarias. Los investigadores de Mayo también estudian los resultados del tratamiento.

Entre los temas de investigación se incluyen los siguientes:

  • Cómo los nuevos medicamentos podrían mejorar el funcionamiento de los vasos sanguíneos.
  • Cómo evolucionan las personas después de una intervención coronaria percutánea y de una cirugía de revascularización miocárdica.

El Centro para Investigación Cardiovascular de Mayo Clinic se centra en desarrollar pruebas de diagnóstico de vanguardia y tratamientos innovadores para las personas que tienen enfermedades cardiovasculares.

Publicaciones

Consulte en PubMed una lista de publicaciones sobre enfermedad de las arterias coronarias escritas por los médicos de Mayo Clinic. PubMed es un servicio de la National Library of Medicine (Biblioteca Nacional de Medicina).

  1. Ferri FF. Coronary artery disease. In: Ferri's Clinical Advisor 2022. Elsevier; 2022. https://www.clinicalkey.com. Accessed March 8, 2022.
  2. Coronary heart disease. National Heart, Lung, and Blood Institute. https://www.nhlbi.nih.gov/health-topics/coronary-heart-disease. March 8, 2022.
  3. Usatine RP, et al., eds. Coronary artery disease. In: Color Atlas and Synopsis of Heart Failure. McGraw Hill; 2019.
  4. Wilson PWF. Overview of the possible risk factors for cardiovascular disease. https://www.uptodate.com/contents/search. Accessed March 8, 2022.
  5. Masjedi MS, et al. Effects of flaxseed on blood lipids in healthy and dyslipidemic subjects: A systematic review and meta-analysis of randomized controlled trials. Current Problems in Cardiology. 2021; doi:10.1016/j.cpcardiol.2021.100931.
  6. Riaz H, et al. Association between obesity and cardiovascular outcomes: A systematic review and meta-analysis of mendelian randomization studies. JAMA Network Open. 2018; doi:10.1001/jamanetworkopen.2018.3788.
  7. Physical Activity Guidelines for Americans. 2nd ed. U.S. Department of Health and Human Services. https://health.gov/our-work/physical-activity/current-guidelines. Accessed March 8, 2022.
  8. Your guide to lowering your cholesterol with therapeutic lifestyle changes (TLC). National Heart, Lung, and Blood Institute. https://www.nhlbi.nih.gov/health-topics/all-publications-and-resources/your-guide-lowering-cholesterol-therapeutic-lifestyle. Accessed March 24, 2022.
  9. Rethinking drinking. National Institute on Alcohol Abuse and Alcoholism. https://www.rethinkingdrinking.niaaa.nih.gov/. Accessed March 24, 2022.
  10. 2015-2020 Dietary Guidelines for Americans. U.S. Department of Health and Human Services and U.S. Department of Agriculture. https://health.gov/our-work/food-nutrition/2015-2020-dietary-guidelines/guidelines. Accessed March 24, 2022.
  11. Omega-3 supplements: In depth. National Center for Complementary and Integrative Health. https://www.nccih.nih.gov/health/omega3-supplements-in-depth. Accessed March 8, 2022.
  12. Medical review (expert opinion). Mayo Clinic. May 9, 2024.
  13. Siscovick DS, et al. Omega-3 polyunsaturated fatty acid (fish oil) supplementation and the prevention of clinical cardiovascular disease: A science advisory from the American Heart Association. Circulation. 2017; doi:10.1161/CIR.0000000000000482.
  14. Barley. Natural Medicines. https://naturalmedicines.therapeuticresearch.com. Accessed March 24, 2022.
  15. Black psyllium. Natural Medicines. https://naturalmedicines.therapeuticresearch.com. Accessed March 24, 2022.
  16. Nimmagadda R. Allscripts EPSi. Mayo Clinic. April 10, 2024.
  17. Liao KP. Coronary artery disease in rheumatoid arthritis: Pathogenesis, risk factors, clinical manifestations, and diagnostic implications. https://www.uptodate.com/contents/search. Accessed March 8, 2022.
  18. What is coronary heart disease? National Heart, Lung, and Blood Institute. https://www.nhlbi.nih.gov/health-topics/coronary-heart-disease Accessed March 8, 2022.
  19. Kannam JP, et al. Chronic coronary syndrome: Overview of care. https://www.uptodate.com/contents/search. Accessed March 8, 2022.
  20. Arnett DK, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019; doi:10.1161/CIR.0000000000000678.
  21. Aspirin use to prevent cardiovascular disease: Preventive medication. U.S. Preventive Services Task Force. https://www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/aspirin-use-to-prevent-cardiovascular-disease-preventive-medication. Accessed March 23, 2021.
  22. Zheng SL, et al. Association of aspirin use for primary prevention with cardiovascular events and bleeding events: A systematic review and meta-analysis. JAMA. 2019; doi:10.1001/jama.2018.20578.
  23. Cutlip D, et al. Revascularization in patients with stable coronary artery disease: Coronary artery bypass graft surgery versus percutaneous coronary intervention. https://www.uptodate.com/contents/search. Accessed March 24, 2022.
  24. Hypertension in Adults: Screening. U.S. Preventive Services Task Force. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/hypertension-in-adults-screening. Accessed March 24, 2022.
  25. How and when to have your cholesterol checked. U.S. Centers for Disease Control and Prevention. https://www.cdc.gov/cholesterol/checked.htm. Accessed March 24, 2022.
  26. Blond psyllium. Natural Medicines. https://naturalmedicines.therapeuticresearch.com. Accessed March 24, 2022.
  27. Oats. Natural Medicines. https://naturalmedicines.therapeuticresearch.com. Accessed March 24, 2022.
  28. Garlic. Natural Medicines. https://naturalmedicines.therapeuticresearch.com. Accessed March 24, 2022.
  29. Plant sterols. Natural Medicines. https://naturalmedicines.therapeuticresearch.com. Accessed March 24, 2022.
  30. Ashraf H, et al. Use of flecainide in stable coronary artery disease: An analysis of its safety in both nonobstructive and obstructive coronary artery disease. American Journal of Cardiovascular Drugs. 2021; doi:10.1007/s40256-021-00483-9.
  31. Ono M, et al. 10-year follow-up after revascularization in elderly patients with complex coronary artery disease. Journal of the American College of Cardiology. 2021; doi:10.1016/j.jacc.2021.04.016.
  32. Coyle M, et al. A critical review of chronic kidney disease as a risk factor for coronary artery disease. International Journal of Cardiology: Heart & Vasculature. 2021; doi:10.1016/j.ijcha.2021.100822.
  33. Medical review (expert opinion). Mayo Clinic. May 9, 2024.
  34. Scientific Report of the 2020 Dietary Guidelines Advisory Committee. Alcoholic beverages. U.S. Department of Health and Human Services and U.S. Department of Agriculture. https://www.dietaryguidelines.gov/2020-advisory-committee-report. Accessed Feb. 1, 2024.
  35. Heart disease in women. American Heart Association. https://www.heart.org/en/health-topics/heart-attack/warning-signs-of-a-heart-attack/heart-attack-symptoms-in-women. May 8, 2024.